LIVINGSTON, N.J., April 28 /PRNewswire-FirstCall/ -- Milestone
Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in
advanced injection technologies, today announced that it will be showcasing
and demonstrating its award winning STA(TM) System at the upcoming
California Dental Association (CDA) 2008 Spring Scientific Session.
WHEN: Thursday, May 1- Sunday, May 4, 2008
WHERE: Booth #1641
Anaheim Convention Center
800 West Katella Avenue
Anaheim, California 92802
WHO: Bob Presutti, Vice President of Sales & Marketing, Milestone
Other Milestone Executives
Sales Representatives from Henry Schein, Inc.
WHAT: Demonstrations of the STA System
-- According to a December 2007 article published in Contemporary
Dental Assistant magazine, "The (STA) instrument is highly
effective in all areas of the oral cavity, including those
areas of dense connective tissue, such as the hard palate.
Dentists can provide traditional block anesthesia and
infiltration injections with this technology; however, special
techniques also may be employed to provide local anesthesia to
the precise teeth targeted for treatment via the periodontal
ligament (PDL) injection. The routine side effects of facial
and lingual numbness from a traditional anesthetic injection
soon may be a thing of the past."
-- Learn first hand how Milestone is redefining the standard of
care of the delivery of local anesthesia in dentistry.
-- Discover how the STA System is improving patient care and the
dental practice efficiency for those dentists who have adopted
CCLAD (Computer Controlled Local Anesthesia Delivery)
technology to more comfortably administer all dental injections
performed in their dental operatories.
NOTE TO PRESS: To arrange one-on-one interviews with Mr. Presutti, or to schedule a personal demonstration of the STA System, please contact John Morrison or Tiffany Korkis, Directors, Elite Media Group, at 407-585-1080 or via email at MLSS@efcg.net.
The CDA Scientific Sessions are held twice a year -- once in the spring and once in the fall. These preeminent sessions offer dynamic speakers, the finest technical exhibits available, and the opportunity to fulfill continuing education requirements. The exhibit hall will showcase approximately 600 vendors and provide an excellent opportunity to review the latest technology and services available to thousands of dental professionals.
The CDA is the largest statewide dental association in the country. Its 24,000 members represent almost 70 percent of dentists practicing in the state. The CDA organization is comprised of CDA, the CDA Foundation, The Dentists Insurance Company and TDIC Insurance Solutions.
Founded in 1870, CDA is part of a membership structure that includes 32 local dental societies and the American Dental Association. CDA represents the single largest membership in the American Dental Association. One out of seven ADA members is also a member of CDA.
About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo(R) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The STA(TM) (Single Tooth Anesthesia) System computer-controlled local anesthesia delivery system which uses this technology provides dentists with audible and visual signals as to in-tissue pressure. Milestone's existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company's web site found at http://www.milesci.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding the
timing and financial impact of the Milestone's ability to implement its
business plan, expected revenues and future success. These statements
involve a number of risks and uncertainties and are based on assumptions
involving judgments with respect to future economic, competitive and market
conditions and future business decisions, all of which are difficult or
impossible to predict accurately and many of which are beyond Milestone's
control. Some of the important factors that could cause actual results to
differ materially from those indicated by the forward-looking statements
are general economic conditions, failure to achieve expected revenue
growth, changes in our operating expenses, adverse patent rulings, FDA or
legal developments, competitive pressures, changes in customer and market
requirements and standards, and the risk factors detailed from time to time
in Milestone's periodic filings with the Securities and Exchange
Commission, including without limitation, Milestone's Annual Report on Form
10-KSB for the year ended December 31, 2007. The forward looking-statements
in this press release are based upon management's reasonable belief as of
the date hereof. Milestone undertakes no obligation to revise or update
publicly any forward-looking statements for any reason.
FOR MORE INFORMATION, PLEASE CONTACT:
Elite Financial Communications Group, LLC Dodi Handy, President and CEO, or Daniel Conway, Chief Strategy Officer
407-585-1080 or via email at email@example.com
|SOURCE Milestone Scientific Inc.|
Copyright©2008 PR Newswire.
All rights reserved